LYPD5 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), the invasive and migratory abilities of cancer cells significantly increase after HO-1 overexpression, decrease after HO-1 silencing and correlate with the expression of metastasis-associated protein EGFR, CD147, and MMP9 [118].